Skip to main content
Clinical Trials/NL-OMON41244
NL-OMON41244
Completed
Phase 3

Optimization of Treatment and Management of Schizophrenia in Europe - the optimise trial

niversitair Medisch Centrum Utrecht0 sites50 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
psychotic disorder
Sponsor
niversitair Medisch Centrum Utrecht
Enrollment
50
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
niversitair Medisch Centrum Utrecht

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of schizophrenia, schizophreniform or schizoaffective disorder as defined by DSM\-IV on the basis of the Mini International Neuropsychiatric Interview Plus (M.I.N.I. Plus; Sheehan et al. 1998\). ;•Age 18\-40 years ;•Written informed consent.

Exclusion Criteria

  • A time interval between the onset of positive symptoms (hallucinations and/or delusions) and study entry exceeding two years.;•Prior use of antipsychotic medication longer than an episode of two weeks in the previous year and/or 6 weeks lifetime.;•Intolerance to one of the drugs in this study.;•Patients who are coercively treated at a psychiatric ward (based on a judicial ruling);•Patients who are represented by a legal ward or under legal custody;•The presence of one or more of the contraindications against any of the study drugs as mentioned in the IB texts;•Pregnancy or lactation

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Optimization of Treatment and Management of Schizophrenia in Europe - OPTiMiSESchizophrenia ICD-10 code F20 or schizophreniform disorder ICD-10 code F23.1MedDRA version: 12.1Level: LLTClassification code 10039626Term: SchizophreniaMedDRA version: 12.1Level: LLTClassification code 10039647Term: Schizophreniform disorder
EUCTR2010-020185-19-GBniversity Medical Centre Utrecht446
Active, not recruiting
Phase 1
Optimising treatment of patient suffering from schizophrenia in Europe
EUCTR2010-020185-19-BEniversity Medical Center Utrecht446
Active, not recruiting
Not Applicable
Optimization of Treatment and Management of Schizophrenia in Europe - OPTiMiSESchizophrenia ICD-10 code F20 or schizophreniform disorder ICD-10 code F23.1MedDRA version: 13.1Level: PTClassification code 10039647Term: Schizophreniform disorderSystem Organ Class: 10037175 - Psychiatric disordersMedDRA version: 13.1Level: PTClassification code 10039626Term: SchizophreniaSystem Organ Class: 10037175 - Psychiatric disorders
EUCTR2010-020185-19-CZniversity Medical Center Utrecht350
Active, not recruiting
Phase 1
Optimising treatment of patient suffering from schizophrenia in EuropeSchizophrenia ICD-10 code F20 or schizophreniform disorder ICD-10 code F23.1MedDRA version: 16.1Level: PTClassification code 10039626Term: SchizophreniaSystem Organ Class: 10037175 - Psychiatric disordersMedDRA version: 16.1Level: PTClassification code 10039647Term: Schizophreniform disorderSystem Organ Class: 10037175 - Psychiatric disorders
EUCTR2010-020185-19-DEniversity Medical Center Utrecht500
Active, not recruiting
Phase 1
Optimising treatment of patient suffering from schizophrenia in EuropeSchizophrenia ICD-10 code F20 or schizophreniform disorder ICD-10 code F23.1MedDRA version: 19.0Level: HLTClassification code 10039620Term: Schizoaffective and schizophreniform disordersSystem Organ Class: 10037175 - Psychiatric disordersMedDRA version: 19.0Level: PTClassification code 10039626Term: SchizophreniaSystem Organ Class: 10037175 - Psychiatric disordersTherapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]
EUCTR2010-020185-19-ROniversity Medical Center Utrecht500